281/399US=55 / Biol/Mol
Pastor-Anglada M, Casado FJ. Nucleoside transport into cells: role of nucleoside transporters SLC28 and SLC29 in cancer chemotherapy. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 1-28. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5.

CANCER; QUIMIOTERAPIA; TRANSPORTE DE NUCLEOSIDEOS; SLC28; SLC29; CONCENTRACAO DE TRANSPORTADOR NUCLEOSIDEO; TRANSPORTADOR NUCLEOSIDO DE EQUILIBRIO; CAPTACAO DE NUCLEOSIDEO; DIFUSAO PASSIVA


282/399US=59 / Enfermagem
Sun V. End-of-life care across settings: palliative chemotherapy and clinical trials in advanced cancer: the nurse's role. In: Ferrell BR, Coyle N. Textbook of palliative nursing. Oxford: University Press, 2006. p. 881-92. ISBN 978-0-19-51549-3.

QUIMIOTERAPIA PALIATIVA; ENSAIOS CLINICOS EM CANCER AVANCADO; PAPEL DO ENFERMEIRO; PACIENTES COM CANCER AVANCADO; QUALIDADE DE VIDA; QUIMIOTERAPIA PALIATIVA; INTENCAO DE TRATAMENTO


283/399Câncer
Ramos AP, Marques GIG, Mendonça YA, Dourado JC, Soares RBA. Clinical evaluation of normal tissue toxicity induced by ionizing radiation in cases of laryngeal carcinoma. Applied Cancer Research, São Paulo: Tecmedd, v.32, n.3, p. 60-3, 2012. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br//applied/ACR2012;32(3)p.60-3.pdf

EFEITOS ADVERSOS; CANCER DE LARINGE; TOXICIDADE; RADIOTERAPIA


284/399US=61 / Câncer
Sovak MA, Spriggs DR. Clinical aspects of resistance: cancer chemotherapy. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 541-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

RESISTENCIA AS DROGAS CLINICA; BIOMARCADORES; CRITERIOS DE RESPOSTA; QUIMIOTERAPIA COMBINADA; MARCADORES SUBSTITUTOS


285/399Câncer
Alberti LR, Lima DCA. A rare case of breast cancer metastasis to the colon: a case report. Applied Cancer Research, São Paulo: Tecmedd, v.32, n.3, p. 99-100, 2012. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br//applied/ACR2012;32(3)p.99-100.pdf

CANCER DE MAMA; COLONOSCOPIA; METASTASES NEOPLASICA


286/399Câncer
Rodríguez MRL, Combariza J, Casas CP, Reveiz L, Buendía J, Carvajal AM, Ramírez HB, Cardona AF. First line therapy for patients with newly diagnosed multiple myeloma ineligible for autologous stem cell transplantation: a systematic review and meta-analysis (hemo-oncolgroup study). Applied Cancer Research, São Paulo: Tecmedd, v.32, n.4, p. 122-41, 2012. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br//applied/ACR2012;32(4)p.122-41.pdf

QUIMIOTERAPIA; META-ANALISES; MIELOMA MULTIPLO; TRANSPLANTE AUTOLOGO


287/399US=7 / Ortopedia
Kalmadi S, Raghavan D. Fundamentals of cancer treatment: effects of chemotherapy on neoplastic cells. In: McLain RF. Cancer in the spine: comprehensive care. New Jersey: Humana Press, 2006. p. 31-42. (Current Clinical Oncology) ISBN 978-1-58829-074-3.

CANCER DA COLUNA; CANCER. TRATAMENTO; QUIMIOTERAPIA; CITOGENETICA; CINETICA DE TUMOR; QUIMIOIRRADIACAO; AGENTES ANTINEOPLASICOS; FARMACOLOGIA; FARMACOCINETICA; FARMACODINAMICA; MECANISMOS DE RESISTENCIA A DROGAS; RESPOSTA DO TUMOR; TRANSPLANTE DE CELULAS ESTAMINAIS; QUIMIOTERAPIA REGIONAL; AGENTES QUIMIOTERAPICOS


288/399US=8 / Quimioterapia
Chabner BA. Clinical strategies for cancer treatment: the role of drugs. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 1-14. ISBN 978-0-7817-5628-6.

CANCER. TERAPIA; PAPEL DAS DROGAS; TERAPIA MEDICAMENTOSA; FARMACOCINETICA; QUIMIOTERAPIA


289/399US=8 / Quimioterapia
Krosky P, Hollingshead M, Shoemaker R, Sausville EA. Preclinical aspects of cancer drug discovery and development. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 15-30. ISBN 978-0-7817-5628-6.

CANCER; DESENVOLVIMENTO DE MEDICAMENTOS; SELECAO DE ALVOS DE DROGAS; TRIAGEM DE DROGAS ANTICANCER; BIBLIOTECAS DE COMPOSTOS; QUIMIOINFORMATICA; INSTITUTO NACIONAL DO CANCER; SISTEMAS DE RASTREAMENTO BASEADOS EM CELULAS; ENSAIOS DE EFICACIA IN VIVO; TECNOLOGIA DA IMAGEM; FARMACOLOGIA PRE-CLINICA; TOXICOLOGIA


290/399US=8 / Quimioterapia
Collins J, Supko JG. Pharmacokinetics. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 31-44. ISBN 978-0-7817-5628-6.

FARMACOCINETICA; DADOS FARMACOCINETICOS; PARAMETROS FARMACOCINETICOS; REGIMES DE DOSAGEM; RELACAO FARMACOCINETICA-FARMACODINAMICA


291/399US=8 / Quimioterapia
Bradbury A, Schilsky RL. Infertility after cancer chemotherapy. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 45-69. ISBN 978-0-7817-5628-6.

CANCER; INFERTILIDADE; QUIMIOTERAPIA; FERTILIDADE MASCULINA; FERTILIDADE FEMININA; EFEITOS DA QUIMIOTERAPIA. CRIANCA


292/399US=8 / Quimioterapia
Blaszkowsky LS, Erlichman C. Carcinogenesis of anticancer drugs. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 70-90. ISBN 978-0-7817-5628-6.

DROGAS ANTICANCER; CARCINOGENESE; CARCINOGENOS QUIMICOS; AGENTES ANTINEOPLASICOS


293/399US=8 / Quimioterapia
Monahan BP, Allegra CJ. Antifolates. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 91-124. ISBN 978-0-7817-5628-6.

ANTIFOLATOS; MECANISMOS DE ACAO; ESTRUTURA QUIMICA; FARMACOLOGIA CELULAR; MECANISMOS DE RESISTENCIA; ENSAIO METOTREXATO; FARMACOCINETICA; METABOLISMO METOTREXATO; TOXICIDADE; SISTEMA NERVOSO CENTRAL; POSOLOGIA CLINICA


294/399US=8 / Quimioterapia
Grem JL. 5-fluoropyrimidines. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 125-82. ISBN 978-0-7817-5628-6.

5-FLUOROPIRIMIDINAS; ESTRUTURA CELULAR; FARMACOLOGIA; MECANISMOS DE ACAO; 5-FLUOROURACIL; FARMACOLOGIA CLINICA; ABSORCAO DO 5-FLUOROURACIL; DISTRIBUICAO DO 5-FLUOROURACIL; CITOTOXICIDADE; MODULACAO DE PIRIMIDINAS; ACIDO FOLINICO


295/399US=8 / Quimioterapia
Ryan DP, Garcia-Carbonero R, Chabner BA. Cytidine analogues. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 183-211. ISBN 978-0-7817-5628-6.

ANALOGOS DA CITIDINA; GEMCITABINA


296/399US=8 / Quimioterapia
Hande KR. Purine antimetabolites. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 212-28. ISBN 978-0-7817-5628-6.

ANTIMETABOLITOS PURINA; ANALOGOS GUANINA; ANALOGOS DA ADENOSINA; ALOPURINOL


297/399US=8 / Quimioterapia
Paz-Ares L, Donehower RC, Chabner BC. Hydroxyurea. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 229-36. ISBN 978-0-7817-5628-6.

HIDROXIUREIA; MECANISMOS DE ACAO; FARMACOLOGIA CELULAR; MECANISMOS DE RESISTENCIA CELULAR; INTERACAO MEDICAMENTOSA; FARMACOLOGIA CLINICA; TOXICIDADE


298/399US=8 / Quimioterapia
Rowinsky EK. Antimicrotubule agents. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 237-82. ISBN 978-0-7817-5628-6.

AGENTES ANTIMICROTUBULOS; ESTRUTURA DE MICROTUBULOS; FUNCAO DOS MICROTUBULOS; VINCA ALCALOIDES; TAXANOS; QUIMICA; FARMACOLOGIA CELULAR; TOXICICIDADE


299/399US=8 / Quimioterapia
Tew KD, Colvin OM, Jones RB. Clinical and high-dose alkylating agents. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 283-309. ISBN 978-0-7817-5628-6.

AGENTES ALQUILANTES CLINICOS; ALTAS DOSES; QUIMICA; FARMACOLOGIA CELULAR; FARMACOLOGIA CLINICA; TOXICIDADE


300/399US=8 / Quimioterapia
Friedman HS, Averbuch SD, Kurtzberg J. Nonclassic agents. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 310-31. ISBN 978-0-7817-5628-6.

PROCARBAZINE; DACARBAZINA; TEMOZOLOMIDA


Primeira | Anterior | Próxima | Última